• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在小鼠肝癌模型中,肥大细胞通过白细胞介素-17 通路在肿瘤微环境中动员髓源抑制细胞和 Treg 细胞。

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model.

机构信息

Department of Biochemistry & Molecular Biology, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, The People's Republic of China.

出版信息

PLoS One. 2010 Jan 27;5(1):e8922. doi: 10.1371/journal.pone.0008922.

DOI:10.1371/journal.pone.0008922
PMID:20111717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2811741/
Abstract

Tumor immunosuppression is commonly braided with chronic inflammation during tumor development. However, the relationship between immunosuppression and inflammation in tumor microenvironment is still unclear. We have demonstrated that mast cells are accumulated and exacerbate the inflammation and immunosuppression in tumor microenvironment via SCF/c-kit signaling pathway. Here, we further elucidate the underlying mechanism, which involves both myeloid-derived suppressor cells (MDSCs) and regulatory T (Treg) cells. Our data showed that mast cells mobilized the infiltration of MDSCs to tumor and induced the production of IL-17 by MDSCs; MDSCs-derived IL-17 indirectly attracted Treg cells, enhanced their suppressor function, and induced the IL-9 production by Treg cells; in turn, IL-9 strengthened the survival and protumor effect of mast cells in tumor microenvironment. Our findings disclose a closed loop among mast cells, MDSCs and Treg cells in tumor microenvironment, which provides a new insight into the paralleled developments of inflammation and immunosuppression in tumor microenvironment. Based on these findings, we propose that targeting tumor inflammation might be a potential strategy to reverse the immunosuppression of tumor microenvironment, thus facilitating cancer immunotherapy.

摘要

肿瘤的免疫抑制通常与肿瘤发展过程中的慢性炎症交织在一起。然而,肿瘤微环境中免疫抑制与炎症之间的关系仍不清楚。我们已经证明,肥大细胞通过 SCF/c-kit 信号通路在肿瘤微环境中积累并加剧炎症和免疫抑制。在这里,我们进一步阐明了这一潜在机制,该机制涉及髓系来源的抑制细胞(MDSCs)和调节性 T 细胞(Treg 细胞)。我们的数据表明,肥大细胞动员 MDSC 浸润肿瘤,并诱导 MDSC 产生白细胞介素-17;MDSC 衍生的白细胞介素-17 间接吸引 Treg 细胞,增强其抑制功能,并诱导 Treg 细胞产生白细胞介素-9;反过来,白细胞介素-9 增强了肿瘤微环境中肥大细胞的存活和促肿瘤作用。我们的研究结果揭示了肿瘤微环境中肥大细胞、MDSC 和 Treg 细胞之间的闭环,为肿瘤微环境中炎症和免疫抑制的平行发展提供了新的见解。基于这些发现,我们提出靶向肿瘤炎症可能是逆转肿瘤微环境免疫抑制、从而促进癌症免疫治疗的一种潜在策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/067a6744e257/pone.0008922.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/42aeea01ae78/pone.0008922.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/69dbc38ad4d7/pone.0008922.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/18680b180f5f/pone.0008922.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/64a7db0e0825/pone.0008922.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/39b54e5100c6/pone.0008922.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/eddbf531dada/pone.0008922.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/067a6744e257/pone.0008922.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/42aeea01ae78/pone.0008922.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/69dbc38ad4d7/pone.0008922.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/18680b180f5f/pone.0008922.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/64a7db0e0825/pone.0008922.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/39b54e5100c6/pone.0008922.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/eddbf531dada/pone.0008922.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42c/2811741/067a6744e257/pone.0008922.g007.jpg

相似文献

1
Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model.在小鼠肝癌模型中,肥大细胞通过白细胞介素-17 通路在肿瘤微环境中动员髓源抑制细胞和 Treg 细胞。
PLoS One. 2010 Jan 27;5(1):e8922. doi: 10.1371/journal.pone.0008922.
2
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.干细胞因子介导的肥大细胞浸润和激活会加剧肿瘤微环境中的炎症和免疫抑制。
Blood. 2008 Aug 15;112(4):1269-79. doi: 10.1182/blood-2008-03-147033. Epub 2008 Jun 4.
3
Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling.肝星状细胞通过白细胞介素 6 信号诱导髓源性抑制细胞增强肝癌进展。
Int J Mol Sci. 2019 Oct 13;20(20):5079. doi: 10.3390/ijms20205079.
4
Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer.手术诱导的单核细胞来源的髓源性抑制细胞可在肺癌中扩增调节性T细胞。
Oncotarget. 2017 Mar 7;8(10):17050-17058. doi: 10.18632/oncotarget.14991.
5
Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment.李斯特菌溶血素 O(LLO)免疫疗法降低了肿瘤微环境中髓源性抑制细胞和调节性 T 细胞的免疫抑制活性。
J Immunother. 2013 Nov-Dec;36(9):468-76. doi: 10.1097/CJI.0000000000000000.
6
Suppression of T cells by myeloid-derived suppressor cells in cancer.癌症中髓源性抑制细胞对T细胞的抑制作用。
Hum Immunol. 2017 Feb;78(2):113-119. doi: 10.1016/j.humimm.2016.12.001. Epub 2016 Dec 7.
7
Passive transfer of lipopolysaccharide-derived myeloid-derived suppressor cells inhibits asthma-related airway inflammation.脂多糖来源的髓源性抑制细胞的被动转移可抑制哮喘相关的气道炎症。
Eur Rev Med Pharmacol Sci. 2015 Nov;19(21):4171-81.
8
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function.晚期恶性肿瘤中免疫耐受的逆转:通过阻断干细胞因子功能调节髓源性抑制细胞的发育。
Blood. 2008 Jan 1;111(1):219-28. doi: 10.1182/blood-2007-04-086835. Epub 2007 Sep 20.
9
IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.白细胞介素-33抑制荷瘤小鼠中粒细胞髓源性抑制细胞的分化和免疫抑制活性。
Immunol Cell Biol. 2017 Jan;95(1):99-107. doi: 10.1038/icb.2016.72. Epub 2016 Aug 10.
10
Repression of MUC1 Promotes Expansion and Suppressive Function of Myeloid-Derived Suppressor Cells in Pancreatic and Breast Cancer Murine Models.MUC1 的抑制促进了胰腺和乳腺癌小鼠模型中髓源性抑制细胞的扩增和抑制功能。
Int J Mol Sci. 2021 May 25;22(11):5587. doi: 10.3390/ijms22115587.

引用本文的文献

1
NR4A3high mast cells promote ovarian cancer metastasis by reprogramming tumor-associated macrophages via JAK2/STAT6 signaling.NR4A3高表达的肥大细胞通过JAK2/STAT6信号通路对肿瘤相关巨噬细胞进行重编程,从而促进卵巢癌转移。
Transl Oncol. 2025 Oct;60:102494. doi: 10.1016/j.tranon.2025.102494. Epub 2025 Aug 10.
2
Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance.肿瘤微环境中的肿瘤驯化细胞:免疫治疗耐药性的关键驱动因素
Chin J Cancer Res. 2025 Jun 30;37(3):446-465. doi: 10.21147/j.issn.1000-9604.2025.03.12.
3
Mast cells: key players in digestive system tumors and their interactions with immune cells.

本文引用的文献

1
Myeloid-derived suppressor cells: linking inflammation and cancer.髓源性抑制细胞:连接炎症与癌症
J Immunol. 2009 Apr 15;182(8):4499-506. doi: 10.4049/jimmunol.0802740.
2
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.通过CCL22/CCR4募集的调节性T细胞在原发性乳腺肿瘤周围的淋巴浸润中被选择性激活,并导致不良临床结局。
Cancer Res. 2009 Mar 1;69(5):2000-9. doi: 10.1158/0008-5472.CAN-08-2360. Epub 2009 Feb 24.
3
IFNgamma promotes papilloma development by up-regulating Th17-associated inflammation.
肥大细胞:消化系统肿瘤中的关键参与者及其与免疫细胞的相互作用
Cell Death Discov. 2025 Jan 15;11(1):8. doi: 10.1038/s41420-024-02258-y.
4
Tumor Immune Microenvironment as a New Therapeutic Target for Hepatocellular Carcinoma Development.肿瘤免疫微环境作为肝细胞癌发展的新治疗靶点
Dev Reprod. 2023 Dec;27(4):167-174. doi: 10.12717/DR.2023.27.4.167. Epub 2023 Dec 31.
5
SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy.SYNPO2 通过上调静止肥大细胞的浸润和增加对免疫治疗的抵抗力促进 BLCA 的发展。
Oncol Rep. 2024 Jan;51(1). doi: 10.3892/or.2023.8673. Epub 2023 Dec 1.
6
Exploiting innate immunity for cancer immunotherapy.利用先天免疫进行癌症免疫治疗。
Mol Cancer. 2023 Nov 27;22(1):187. doi: 10.1186/s12943-023-01885-w.
7
Heterogeneity of the tumor immune microenvironment and clinical interventions.肿瘤免疫微环境的异质性与临床干预
Front Med. 2023 Aug;17(4):617-648. doi: 10.1007/s11684-023-1015-9. Epub 2023 Sep 20.
8
Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy.微环境中的“亦敌亦友”:利用肥大细胞进行癌症免疫治疗
Pharmaceutics. 2023 Jun 9;15(6):1692. doi: 10.3390/pharmaceutics15061692.
9
Here, There, and Everywhere: Myeloid-Derived Suppressor Cells in Immunology.无处不在的髓系来源抑制细胞:在免疫学中的作用
J Immunol. 2023 May 1;210(9):1183-1197. doi: 10.4049/jimmunol.2200914.
10
Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective.针对胰腺癌免疫治疗的肿瘤免疫抑制微环境:当前研究与未来展望
Front Oncol. 2023 Mar 29;13:1166860. doi: 10.3389/fonc.2023.1166860. eCollection 2023.
γ干扰素通过上调Th17相关炎症促进乳头瘤发展。
Cancer Res. 2009 Mar 1;69(5):2010-7. doi: 10.1158/0008-5472.CAN-08-3479. Epub 2009 Feb 24.
4
Myeloid-derived suppressor cells as regulators of the immune system.髓源性抑制细胞作为免疫系统的调节因子。
Nat Rev Immunol. 2009 Mar;9(3):162-74. doi: 10.1038/nri2506.
5
The roles of IL-17A in inflammatory immune responses and host defense against pathogens.白细胞介素-17A在炎症免疫反应及宿主抵御病原体过程中的作用。
Immunol Rev. 2008 Dec;226:57-79. doi: 10.1111/j.1600-065X.2008.00699.x.
6
Immune therapy for cancer.癌症免疫疗法
Annu Rev Immunol. 2009;27:83-117. doi: 10.1146/annurev.immunol.021908.132544.
7
IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma.产生白细胞介素-17的肺泡巨噬细胞介导与哮喘相关的过敏性肺部炎症。
J Immunol. 2008 Nov 1;181(9):6117-24. doi: 10.4049/jimmunol.181.9.6117.
8
CTLA-4 control over Foxp3+ regulatory T cell function.细胞毒性T淋巴细胞相关抗原4对叉头框蛋白3阳性调节性T细胞功能的调控
Science. 2008 Oct 10;322(5899):271-5. doi: 10.1126/science.1160062.
9
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.干细胞因子介导的肥大细胞浸润和激活会加剧肿瘤微环境中的炎症和免疫抑制。
Blood. 2008 Aug 15;112(4):1269-79. doi: 10.1182/blood-2008-03-147033. Epub 2008 Jun 4.
10
Regulatory T cells and immune tolerance.调节性T细胞与免疫耐受。
Cell. 2008 May 30;133(5):775-87. doi: 10.1016/j.cell.2008.05.009.